Plasmodium malariae

Last updated

Contents

Plasmodium malariae
Mature Plasmodium malariae schizont PHIL 2715 lores.jpg
Giemsa-stained micrograph of a mature Plasmodium malariae schizont
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Eukaryota
Clade: Diaphoretickes
Clade: SAR
Clade: Alveolata
Phylum: Apicomplexa
Class: Aconoidasida
Order: Haemospororida
Family: Plasmodiidae
Genus: Plasmodium
Species:
P. malariae
Binomial name
Plasmodium malariae
(Feletti & Grassi, 1889)
Synonyms [1]
  • Haemamoeba malariaeFeletti and Grassi, 1889
  • Plasmodium malariae var. quartanaeCelli and Sanfelice, 1891
  • Plasmodium malariae quartanaeKruse, 1892
  • Haemamoeba laverani var. quartanaeLabbe, 1894
  • Plasmodium rodhainiBrumpt, 1939

Plasmodium malariae is a parasitic protozoan that causes malaria in humans. It is one of several species of Plasmodium parasites that infect other organisms as pathogens, also including Plasmodium falciparum and Plasmodium vivax , responsible for most malarial infection. Found worldwide, it causes a so-called "benign malaria", not nearly as dangerous as that produced by P. falciparum or P. vivax. The signs include fevers that recur at approximately three-day intervals – a quartan fever or quartan malaria – longer than the two-day (tertian) intervals of the other malarial parasite.

History

Malaria has been recognized since the Greek and Roman civilizations over 2,000 years ago, with different patterns of fever described by the early Greeks. [2] In 1880, Alphonse Laveran discovered that the causative agent of malaria is a parasite. [2] Detailed work of Golgi in 1886 demonstrated that in some patients there was a relationship between the 72-hour life cycle of the parasite and the chill and fever patterns in the patient. [2] The same observation was found for parasites with 48-hour cycles. [2] Golgi concluded that there must be more than one species of malaria parasite responsible for these different patterns of infection. [2]

Epidemiology

Relative incidence of Plasmodium species by country of origin for imported cases to non-endemic countries, showing P. malariae in yellow. Relative incidence of Plasmodium (malaria) species by country of origin for imported cases to non-endemic countries.png
Relative incidence of Plasmodium species by country of origin for imported cases to non-endemic countries, showing P. malariae in yellow.

Each year, approximately 500 million people will be infected with malaria worldwide. [4] Of those infected, roughly two million will die from the disease. [5] Malaria is caused by six Plasmodium species: Plasmodium falciparum , Plasmodium vivax, Plasmodium ovale curtisi , Plasmodium ovale wallikeri , Plasmodium malariae and Plasmodium knowlesi . [2] At any one time, an estimated 300 million people are said to be infected with at least one of these Plasmodium species and so there is a great need for the development of effective treatments for decreasing the yearly mortality and morbidity rates. [6]

Geographical areas of malaria transmission Geographical areas of malaria transmission 2014.png
Geographical areas of malaria transmission

P. malariae is the one of the least studied of the six species that infect humans, in part because of its low prevalence and milder clinical manifestations compared to the other species. It is widespread throughout sub-Saharan Africa, much of southeast Asia, Indonesia, on many of the islands of the western Pacific and in areas of the Amazon Basin of South America. [5] In endemic regions, prevalence ranges from less than 4% to more than 20%, [7] but there is evidence that P. malariae infections are vastly underreported. [8]

The Centers for Disease Control (CDC) has an application that allows people to view specific parts of the world and how they are affected by Plasmodium vivax, and other types of the Plasmodium parasite. It can be found at the following link: http://cdc.gov/malaria/map/index.html.

Role in disease

P. malariae can infect several species of mosquito and can cause malaria in humans. [2] P. malariae can be maintained at very low infection rates among a sparse and mobile population because unlike the other Plasmodium parasites, it can remain in a human host for an extended period of time and still remain infectious to mosquitoes. [8]

Vector

The vector of transmission of the parasite is the female Anopheles mosquito, but many different species have been shown to transmit the parasite at least experimentally. [2] Collins and Jeffrey report over thirty different species, which vary by geographic region. [2]

Incubation period

Information about the prepatent period, or the period of time between the infection of the parasite and demonstration of that parasite within the body, of P. malariae associated malaria is limited, but the data suggests that there is great variation, often the length of time depending on the strain of P. malariae parasite. [2] Usually, the prepatent period ranges from 16 to 59 days. [2]

Infection in humans

Plasmodium malariae causes a chronic infection that in some cases can last a lifetime. The P. malariae parasite has several differences between it and the other Plasmodium parasites, one being that maximum parasite counts are usually low compared to those in patients infected with P. falciparum or P. vivax. [2] The reason for this can possibly be accounted for by the lower number of merozoites produced per erythrocytic cycle, the longer 72-hour developmental cycle (compared to the 48-hour cycle of P. vivax and P. falciparum), the preference for development in older erythrocytes and the resulting earlier development of immunity by the human host. [2] Another defining feature of P. malariae is that the fever manifestations of the parasite are more moderate relative to those of P. falciparum and P. vivax and fevers show quartan periodicity. [7] Along with bouts of fever and more general clinical symptoms such as chills and nausea, the presence of edema and the nephrotic syndrome has been documented with some P. malariae infections. [2] It has been suggested that immune complexes may cause structural glomerular damage and that renal disease may also occur. [2] Although P. malariae alone has a low morbidity rate, it does contribute to the total morbidity caused by all Plasmodium species, as manifested in the incidences of anemia, low birth rate and reduced resistance to other infections. [7]

Due to a similarity in the appearances of the pathogens, P. knowlesi infections are often misdiagnosed as P. malariae infections. Molecular analysis is usually required for an accurate diagnosis. [9]

Diagnostics

The preferable method for diagnosis of P. malariae is through the examination of peripheral blood films stained with Giemsa stain. [2] PCR techniques are also commonly used for diagnoses confirmation as well as to separate mixed Plasmodium infections. [2] Even with these techniques, however, it may still be impossible to differentiate infections, as is the case in areas of South America where humans and monkeys coexist and P. malariae and P. brasilianum are not easily distinguishable. [2]

Biology

As a protist, Plasmodium is a eukaryote of the phylum Apicomplexa. Unusual characteristics of this organism in comparison to general eukaryotes include the rhoptry, micronemes, and polar rings near the apical end. Plasmodium is known best for the infection it causes in humans, namely, malaria. Plasmodium.png
As a protist, Plasmodium is a eukaryote of the phylum Apicomplexa. Unusual characteristics of this organism in comparison to general eukaryotes include the rhoptry, micronemes, and polar rings near the apical end. Plasmodium is known best for the infection it causes in humans, namely, malaria.

Life cycle

Plasmodium malariae wiki Falciparum-life-cycle-final.jpg
Plasmodium malariae wiki

P. malariae is the only human malaria parasite that causes fevers which recur at approximately three-day intervals (therefore occurring every fourth day, a quartan fever), longer than the two-day (tertian) intervals of the other malarial parasites. [10]

Human infection

Liver stage and blood stage

In the liver stage, many thousands of merozoites are produced in each schizont. [2] As the merozoites are released, they invade erythrocytes and initiate the erythrocytic cycle, where the parasite digests hemoglobin to obtain amino acids for protein synthesis. [5]

The total length of the intraerythrocytic development is roughly 72 hours for P. malariae. [11]

At the schizont stage, after schizogonic division, there are roughly 6–8 parasite cells in the erythrocyte. [11]

Following the erythrocytic cycle, which lasts for seventy two hours on average, six to fourteen merozoites are released to reinvade other erythrocytes. [2] Finally, some of the merozoites develop into either micro- or macrogametocytes. [2] The two types of gametocytes are taken into the mosquito during feeding and the cycle is repeated. [2] There are no animal reservoirs for P. malariae.

Mosquito stage

Similar to the other human-infecting Plasmodium parasites, Plasmodium malariae has distinct developmental cycles in the Anopheles mosquito and in the human host. [2] The mosquito serves as the definitive host and the human host is the intermediate. [2] When the Anopheles mosquito takes a blood meal from an infected individual, gametocytes are ingested from the infected person. [2] A process known as exflagellation of the microgametocyte soon ensues and up to eight mobile microgametes are formed. [2]

Sexual stage

Following fertilization of the macrogamete, a mobile ookinete is formed, which penetrates the peritropic membrane surrounding the blood meal and travels to the outer wall of the mid-gut of the mosquito. [2] The oocyst then develops under the basal membrane and after a period of two to three weeks a variable amount of sporozoites are produced within each oocyst. [2] The number of sporozoites that are produced varies with temperature and can range from anywhere between many hundreds to a few thousand. [2] Eventually, the oocyst ruptures and the sporozoites are released into the hemocoel of the mosquito. The sporozoites are then carried by the circulation of the hemolymph to the salivary glands, where they become concentrated in the acinal cells. [2] A small number of sporozoites are introduced into the salivary duct and injected into the skin of the bitten human. [12] This subsequently leads to the cycle in the human liver. [2]

Morphology

The ring stages that are formed by the invasion of merozoites released by rupturing liver stage schizonts are the first stages that appear in the blood. [2] The ring stages grow slowly but soon fill one-fourth to one-third of the parasitized cell. [2] Pigment increases rapidly and the half-grown parasite may have from 30 to 50 jet-black granules. [2] The parasite changes various shapes as it grows and stretches across the host cell to form the band form. [2]

Laboratory considerations

P. vivax and P. ovale sitting in EDTA for more than 30 minutes before the blood film is made will look very similar in appearance to P. malariae, which is an important reason to warn the laboratory immediately when the blood sample is drawn so they can process the sample as soon as it arrives.

Microscopically, the parasitised red blood cell (erythrocyte) is never enlarged and may even appear smaller than that of normal red blood cells. The cytoplasm is not decolorized and no dots are visible on the cell surface. The food vacuole is small and the parasite is compact. Cells seldom host more than one parasite. Band forms, where the parasite forms a thick band across the width of the infected cell, are characteristic of this species (and some would say is diagnostic). Large grains of malarial pigment are often seen in these parasites: more so than any other Plasmodium species, 8 merozoites.

Management and therapy

Failure to detect some P. malariae infections has led to modifications of the species-specific primers and to efforts towards the development of real-time PCR assays. [2] The development of such an assay has included the use of generic primers that target a highly conserved region of the 18S rRNA genes of the four human-infecting species of Plasmodium. [2] This assay was found to be highly specific and sensitive. Although serologic tests are not specific enough for diagnostic purposes, they can be used as basic epidemiologic tools. [2] The immunofluorescent-antibody (IFA) technique can be used to measure the presence of antibodies to P. malariae.. [2] A pattern has emerged in which an infection of short duration causes a rapidly declining immune response, but upon re-infection or recrudescence, the IFA level rises significantly and remains present for many months or years. [5]

The increasing need to correctly identify P. malariae infection is underscored by its possible anti-malarial resistance. In a study by Müller-Stöver et al., the researchers presented three patients who were found to be infected with the parasite after taking anti-malarial medications. [13] Given the slower pre-erythrocytic development and longer incubation period compared to the other malaria causing Plasmodium species, the researchers hypothesized that the anti-malarials may not be effective enough against the pre-erythrocytic stages of P. malariae. [13] They thought that further development of P. malariae can occur when plasma concentrations of the anti-malarials gradually decrease after the anti-malarial medications are taken. According to Dr. William E. Collins from the Center of Disease Control (CDC), chloroquine is most commonly used for treatment and no evidence of resistance to this drug has been found. [14] In that event, it is possible that the results from Müller-Stöver et al. provided isolated incidences.

Public health, prevention strategies and vaccines

The food vacuole is the specialized compartment that degrades hemoglobin during the asexual erythrocytic stage of the parasite. [6] It is implied that effective drug treatments can be developed by targeting the proteolytic enzymes of the food vacuole. In a paper published in 1997, Westling et al. [5] focused their attention on the aspartic endopeptidase class of enzymes, simply called plasmepsins. They sought to characterize the specificity for the enzymes cloned from P. vivax and P. malariae. Using substrate specificity studies and inhibitor analysis, it was found that the plasmepsins for P. malariae and P. vivax showed less specificity than that for P. falciparum. Unfortunately, this means that the development of a selective inhibitor for P. malariae may prove more challenging than the development of one for P. falciparum. [5] Another study by Bruce et al. [7] presented evidence that there may be regular genetic exchange within P. malariae populations. Six polymorphic genetic markers from P. malariae were isolated and analyzed in 70 samples of naturally acquired P. malariae infections from different parts of the world. The data showed a high level of multi-genotypic carriage in humans. [7]

Both of these experiments illustrate that development of vaccine options will prove challenging, if not impossible. Dr. William Collins doubts that anyone is currently looking for possible vaccines for P. malariae [14] and given the complexity of the parasite it can be inferred why. He states that very few studies are conducted with this parasite, [14] perhaps as a result of its perceived low morbidity and prevalence. Collins cites the great restrictions of studies with chimpanzees and monkeys as a sizeable barrier. [14] Since the Plasmodium brasilianium parasite that infects South American monkeys is thought to be an adapted form of P. malariae, more research with P. brasilianium may hold valuable insight into P. malariae.

A recent study shows that quartan malaria parasites are easily exchanged between humans and monkeys in Latin America. Thus, a lack of host specificity in mammalian hosts can be hypothesized and quartan malaria can be considered to be a true anthropozoonosis. [15]

The continuing work with the plasmepsin associated with P. malariae, plasmepsin 4, by Professor Ben Dunn and his research team from the University of Florida may provide hope for long term malaria control in the near future. [16]

Genome

In 2017 the full genome was published. [17] The sequences can be accessed on geneDB.org and plasmoDB.org.

See also

Related Research Articles

<span class="mw-page-title-main">Malaria</span> Mosquito-borne infectious disease

Malaria is a mosquito-borne infectious disease that affects humans and other vertebrates. Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches. In severe cases, it can cause jaundice, seizures, coma, or death. Symptoms usually begin 10 to 15 days after being bitten by an infected Anopheles mosquito. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, reinfection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria.

<i>Plasmodium</i> Genus of parasitic protists that can cause malaria

Plasmodium is a genus of unicellular eukaryotes that are obligate parasites of vertebrates and insects. The life cycles of Plasmodium species involve development in a blood-feeding insect host which then injects parasites into a vertebrate host during a blood meal. Parasites grow within a vertebrate body tissue before entering the bloodstream to infect red blood cells. The ensuing destruction of host red blood cells can result in malaria. During this infection, some parasites are picked up by a blood-feeding insect, continuing the life cycle.

<i>Plasmodium falciparum</i> Protozoan species of malaria parasite

Plasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans. The parasite is transmitted through the bite of a female Anopheles mosquito and causes the disease's most dangerous form, falciparum malaria. It is responsible for around 50% of all malaria cases. P. falciparum is therefore regarded as the deadliest parasite in humans. It is also associated with the development of blood cancer and is classified as a Group 2A (probable) carcinogen.

<span class="mw-page-title-main">Gametocyte</span> Eukaryotic germ stem cell

A gametocyte is a eukaryotic germ cell that divides by mitosis into other gametocytes or by meiosis into gametids during gametogenesis. Male gametocytes are called spermatocytes, and female gametocytes are called oocytes.

<span class="mw-page-title-main">Giovanni Battista Grassi</span> Italian physician and zoologist (1854–1925)

Giovanni Battista Grassi was an Italian physician and zoologist, best known for his pioneering works on parasitology, especially on malariology. He was Professor of Comparative Zoology at the University of Catania from 1883, and Professor of Comparative Anatomy at Sapienza University of Rome from 1895 until his death. His first major research on the taxonomy and biology of termites earned him the Royal Society's Darwin Medal in 1896.

<span class="mw-page-title-main">Primaquine</span> Pharmaceutical drug

Primaquine is a medication used to treat and prevent malaria and to treat Pneumocystis pneumonia. Specifically it is used for malaria due to Plasmodium vivax and Plasmodium ovale along with other medications and for prevention if other options cannot be used. It is an alternative treatment for Pneumocystis pneumonia together with clindamycin. It is taken by mouth.

Recrudescence is the recurrence of an undesirable condition. In medicine, it is usually defined as the recurrence of symptoms after a period of remission or quiescence, in which sense it can sometimes be synonymous with relapse. In a narrower sense, it can also be such a recurrence with higher severity than before the remission. "Relapse" conventionally has a specific meaning when used in relation to malaria.

<i>Plasmodium vivax</i> Species of single-celled organism

Plasmodium vivax is a protozoal parasite and a human pathogen. This parasite is the most frequent and widely distributed cause of recurring malaria. Although it is less virulent than Plasmodium falciparum, the deadliest of the five human malaria parasites, P. vivax malaria infections can lead to severe disease and death, often due to splenomegaly. P. vivax is carried by the female Anopheles mosquito; the males do not bite.

<i>Plasmodium ovale</i> Species of single-celled organism

Plasmodium ovale is a species of parasitic protozoon that causes tertian malaria in humans. It is one of several species of Plasmodium parasites that infect humans, including Plasmodium falciparum and Plasmodium vivax which are responsible for most cases of malaria in the world. P. ovale is rare compared to these two parasites, and substantially less dangerous than P. falciparum.

<i>Plasmodium knowlesi</i> Species of single-celled organism

Plasmodium knowlesi is a parasite that causes malaria in humans and other primates. It is found throughout Southeast Asia, and is the most common cause of human malaria in Malaysia. Like other Plasmodium species, P. knowlesi has a life cycle that requires infection of both a mosquito and a warm-blooded host. While the natural warm-blooded hosts of P. knowlesi are likely various Old World monkeys, humans can be infected by P. knowlesi if they are fed upon by infected mosquitoes. P. knowlesi is a eukaryote in the phylum Apicomplexa, genus Plasmodium, and subgenus Plasmodium. It is most closely related to the human parasite Plasmodium vivax as well as other Plasmodium species that infect non-human primates.

Plasmodium eylesi is a parasite of the genus Plasmodium subgenus Plasmodium.

Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.

<span class="mw-page-title-main">History of malaria</span> History of malaria infections

The history of malaria extends from its prehistoric origin as a zoonotic disease in the primates of Africa through to the 21st century. A widespread and potentially lethal human infectious disease, at its peak malaria infested every continent except Antarctica. Its prevention and treatment have been targeted in science and medicine for hundreds of years. Since the discovery of the Plasmodium parasites which cause it, research attention has focused on their biology as well as that of the mosquitoes which transmit the parasites.

Hematozoa is a subclass of blood parasites of the Apicomplexa clade. Well known examples include the Plasmodium spp. which cause malaria in humans and Theileria which causes theileriosis in cattle. A large number of species are known to infect birds and are transmitted by insect vectors. The pattern in which Haematozoa infect a host cell depends on the genera of the blood parasite. Plasmodium and Leucozytozoon displace the nucleus of the host cell so that the parasite can take control of the cell where as Hemoproteus completely envelops the nucleus in a host cell.

<span class="mw-page-title-main">Apicomplexan life cycle</span> Apicomplexa life cycle

Apicomplexans, a group of intracellular parasites, have life cycle stages that allow them to survive the wide variety of environments they are exposed to during their complex life cycle. Each stage in the life cycle of an apicomplexan organism is typified by a cellular variety with a distinct morphology and biochemistry.

Pregnancy-associated malaria (PAM) or placental malaria is a presentation of the common illness that is particularly life-threatening to both mother and developing fetus. PAM is caused primarily by infection with Plasmodium falciparum, the most dangerous of the four species of malaria-causing parasites that infect humans. During pregnancy, a woman faces a much higher risk of contracting malaria and of associated complications. Prevention and treatment of malaria are essential components of prenatal care in areas where the parasite is endemic – tropical and subtropical geographic areas. Placental malaria has also been demonstrated to occur in animal models, including in rodent and non-human primate models.

Plasmodium coatneyi is a parasitic species that is an agent of malaria in nonhuman primates. P. coatneyi occurs in Southeast Asia. The natural host of this species is the rhesus macaque and crab-eating macaque, but there has been no evidence that zoonosis of P. coatneyi can occur through its vector, the female Anopheles mosquito.

<i>Plasmodium cynomolgi</i> Species of single-celled organism

Plasmodium cynomolgi is an apicomplexan parasite that infects mosquitoes and Asian Old World monkeys. In recent years, a number of natural infections of humans have also been documented. This species has been used as a model for human Plasmodium vivax because Plasmodium cynomolgi shares the same life cycle and some important biological features with P. vivax.

<span class="mw-page-title-main">Quartan fever</span> Medical condition

Quartan fever is one of the four types of malaria which can be contracted by humans.

References

  1. ↑ Coatney GR, Collins WE, Warren M, Contacos PG (1971). "18 Plasmodium malariae (Grassi and Feletti, 1890)". The primate malarias. Division of Parasitic Disease, CDC. p. 209.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 Collins WE, Jeffery GM (October 2007). "Plasmodium malariae: parasite and disease". Clinical Microbiology Reviews. 20 (4): 579–92. doi:10.1128/CMR.00027-07. PMC   2176047 . PMID   17934075.
  3. ↑ Tatem AJ, Jia P, Ordanovich D, Falkner M, Huang Z, Howes R; et al. (2017). "The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics". Lancet Infect Dis. 17 (1): 98–107. doi:10.1016/S1473-3099(16)30326-7. PMC   5392593 . PMID   27777030.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ↑ Madabushi A, Chakraborty S, Fisher SZ, Clemente JC, Yowell C, Agbandje-McKenna M, Dame JB, Dunn BM, McKenna R (February 2005). "Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae". Acta Crystallographica Section F. 61 (Pt 2): 228–31. doi:10.1107/S1744309105001405. PMC   1952262 . PMID   16511002.
  5. 1 2 3 4 5 6 Westling J, Yowell CA, Majer P, Erickson JW, Dame JB, Dunn BM (November 1997). "Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite". Experimental Parasitology. 87 (3): 185–93. doi:10.1006/expr.1997.4225. PMID   9371083.
  6. 1 2 Clemente JC, Govindasamy L, Madabushi A, Fisher SZ, Moose RE, Yowell CA, Hidaka K, Kimura T, Hayashi Y, Kiso Y, Agbandje-McKenna M, Dame JB, Dunn BM, McKenna R (March 2006). "Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor". Acta Crystallographica Section D. 62 (Pt 3): 246–52. Bibcode:2006AcCrD..62..246C. doi:10.1107/S0907444905041260. PMID   16510971.
  7. 1 2 3 4 5 Bruce MC, Macheso A, Galinski MR, Barnwell JW (May 2007). "Characterization and application of multiple genetic markers for Plasmodium malariae". Parasitology. 134 (Pt 5): 637–50. doi:10.1017/S0031182006001958. PMC   1868962 . PMID   17140466.
  8. 1 2 Mohapatra PK, Prakash A, Bhattacharyya DR, Goswami BK, Ahmed A, Sarmah B, Mahanta J (July 2008). "Detection & molecular confirmation of a focus of Plasmodium malariae in Arunachal Pradesh, India". The Indian Journal of Medical Research. 128 (1): 52–6. PMID   18820359.
  9. ↑ Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ (March 2004). "A large focus of naturally acquired Plasmodium knowlesi infections in human beings" (PDF). Lancet. 363 (9414): 1017–24. doi:10.1016/S0140-6736(04)15836-4. PMID   15051281. S2CID   7776536.
  10. ↑ "Biology: Malaria (CDC malaria)". Archived from the original on 13 October 2008.
  11. 1 2 "Malaria eModule - ASEXUAL ERYTHROCYTIC STAGES".
  12. ↑ Ménard, R; Tavares, J; Cockburn, I; Markus, M; Zavala, F; Amino, R (2013). "Looking under the skin: the first steps in malarial infection and immunity". Nature Reviews Microbiology. 11 (10): 701–712. doi: 10.1038/nrmicro3111 . PMID   24037451. S2CID   21437365.
  13. 1 2 Müller-Stöver I, Verweij JJ, Hoppenheit B, Göbels K, Häussinger D, Richter J (February 2008). "Plasmodium malariae infection in spite of previous anti-malarial medication". Parasitology Research. 102 (3): 547–50. doi:10.1007/s00436-007-0804-4. PMID   18060428. S2CID   12491253.
  14. 1 2 3 4 Collins, William. "RE: Current research on Plasmodium malariae." Email to Chibuzo Eke. 18 February 2009.
  15. ↑ Albert Lalremruata, Magda Magris, Sarai Vivas-Martínez, Maike Koehler, Meral Esen (September 2015), "Natural infection of Plasmodium brasilianum in humans: Man and monkey share quartan malaria parasites in the Venezuelan Amazon", eBioMedicine, vol. 2, no. 9, pp. 1186–1192, doi: 10.1016/j.ebiom.2015.07.033 , PMC   4588399 , PMID   26501116 {{citation}}: CS1 maint: multiple names: authors list (link)
  16. ↑ Dunn, Ben."RE:Current research on Plasmodium malariae." Email to Chibuzo Eke. 18 February 2009.
  17. ↑ Rutledge GG, Böhme U, Sanders M, Reid AJ, Cotton JA, Maiga-Ascofare O, Djimdé AA, Apinjoh TO, Amenga-Etego L, Manske M, Barnwell JW, Renaud F, Ollomo B, Prugnolle F, Anstey NM, Auburn S, Price RN, McCarthy JS, Kwiatkowski DP, Newbold CI, Berriman M, Otto TD (February 2017). "Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution". Nature. 542 (7639): 101–104. Bibcode:2017Natur.542..101R. doi:10.1038/nature21038. PMC   5326575 . PMID   28117441.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.